Christopher P. Cannon, MD - Optimizing Management of Dyslipidemia: Risk Assessment, Treatment Targets, and Adherence

Summary: In this activity, experts in management of dyslipidemia discuss the optimal assessment of cardiovascular risk in patients with dyslipidemia, including the role of novel markers such as hs-CRP; optimal treatment goals based on cardiovascular risk; and strategies to maximize adherence to long-term therapy and lifestyle interventions.